These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Monitoring of interferon treatment in patients with renal cell carcinoma and bladder carcinoma by oligo-A synthetase assay and determination of immunological parameters. Grups JW; Komprecht B J Biol Regul Homeost Agents; 1989; 3(3):98-101. PubMed ID: 2516404 [TBL] [Abstract][Full Text] [Related]
45. 2',5'-Oligoadenylate synthetase levels in patients with multiple myeloma receiving maintenance therapy with interferon alpha 2b do not correlate with clinical response. Millar BC; Bell JB Br J Cancer; 1995 Dec; 72(6):1525-30. PubMed ID: 8519671 [TBL] [Abstract][Full Text] [Related]
46. Induction and measurement of 2',5'-oligoadenylate synthetase in Madin-Darby bovine kidney cells and in cattle. Short EC; Fulton RW J Clin Microbiol; 1987 Sep; 25(9):1735-40. PubMed ID: 2443533 [TBL] [Abstract][Full Text] [Related]
47. Interferon-induced cytotoxicity and (2'-5') oligo(A) synthetase activity in T cells. Differences in responsiveness among T cells from various individuals and among lymphoblastoid T-cell lines. Gazitt Y; Ben-Bassat H; Wallach D; Revel M; Schattner A Clin Immunol Immunopathol; 1984 Jan; 30(1):71-9. PubMed ID: 6607796 [TBL] [Abstract][Full Text] [Related]
48. [Demonstration of 2-5A synthetase in human circulating mononuclear cells after oral administration of an interferon inducer isolated from a fraction of Escherichia coli and Klebsiella pneumoniae]. Merlin G; Vanderhoven C; Page YM; Falcoff E C R Acad Sci III; 1985; 300(17):619-22. PubMed ID: 3939289 [TBL] [Abstract][Full Text] [Related]
49. Clinical value of the determination of an interferon-induced enzyme activity: studies of the 2'5' oligoadenylate synthetase activity in peripheral blood lymphocytes of patients. Chousterman S; Chousterman M; Reinert P; Thang MN Biomed Pharmacother; 1983; 37(4):176-80. PubMed ID: 6198003 [TBL] [Abstract][Full Text] [Related]
50. Interferon inhibits prostaglandin E2 synthesis and stimulates (2'-5')oligoadenylate synthetase activity in peripheral blood mononuclear cells of inflammatory bowel disease patients. Rachmilewitz D; Karmeli F; Panet A J Interferon Res; 1985; 5(4):629-35. PubMed ID: 2418132 [TBL] [Abstract][Full Text] [Related]
51. Elevated levels of interferon-induced 2'-5' oligoadenylate synthetase in generalized persistent lymphadenopathy and the acquired immunodeficiency syndrome. Read SE; Williams BR; Coates RA; Evans WK; Fanning MM; Garvey MB; Shepherd FA J Infect Dis; 1985 Sep; 152(3):466-72. PubMed ID: 2411826 [TBL] [Abstract][Full Text] [Related]
52. Evidence for interferon (IFN) induction in mice and humans by a fraction of bacterial extracts (SLO4) in vitro and after oral administration in vivo. Merlin G; Vanderhoven C; Stefanos S; Wietzerbin J; Girard JP; Page Y; Falcoff E Antiviral Res; 1985; Suppl 1():161-6. PubMed ID: 3936411 [No Abstract] [Full Text] [Related]
54. Decreased interferon binding capacity of peripheral blood mononuclear cells during interferon treatment of chronic hepatitis B with special reference to (2'-5') oligoadenylate synthetase activity. Shindo M; Iwata A; Okuno T; Matsumoto M; Takeda M; Arai K; Sokawa Y Gastroenterol Jpn; 1989 Dec; 24(6):670-5. PubMed ID: 2481600 [TBL] [Abstract][Full Text] [Related]
55. 2',5' Oligoadenylate synthetase activity in peripheral blood mononuclear cells and serum during interferon treatment of chronic non-A, non-B hepatitis. Okuno T; Shindo M; Arai K; Matsumoto M; Takeda M; Kashima K; Sokawa Y Gastroenterol Jpn; 1991 Oct; 26(5):603-10. PubMed ID: 1752391 [TBL] [Abstract][Full Text] [Related]
56. 2',5'-Oligoadenylate synthetase activity in peripheral blood lymphocytes as a clinical marker in interferon therapy for chronic hepatitis B. Furuta M; Akashi K; Nakamura Y; Matsumoto K; Yamaguchi H; Takamatsu S; Shimizu T J Interferon Res; 1987 Feb; 7(1):111-9. PubMed ID: 3585079 [TBL] [Abstract][Full Text] [Related]